Breaking News

SNBL USA Appoints Lab Services Director

October 24, 2013

Breau brings 20 years of experience

Alan Breau, Ph.D., has been appointed director of laboratory services at SNBL USA. Dr. Breau has 20 years of industry experience and will provide scientific and innovative oversight of SNBL’s scientific research for clients in the areas of flow cytometry, virology, formulations and analytical chemistry as well as other preclinical services.
 
Dr. Breau has more than 20 years of project team experience with early discovery and development projects. Prior to joining the company, he was the chief operating officer and co-founder of CRO Biologics Development Services and vice president of analytical services at MPI Research. He has also held various positions managing bioanalytical, analytical and immunology departments that provided analytical services for clients developing small molecules, large molecules and hybrid molecules such as antibody drug conjugates. 
 
"Alan has the perfect background and experience to direct SNBL USA’s laboratory services team,” said Dr. Thomas Beck, SNBL USA president and chief operating officer. "He will drive the vision and strategy for our laboratory services group and streamline efficiencies. With his scientific, industry and corporate experiences, Alan will provide an important new dimension as SNBL USA expands our support to the scientific priorities of our clients while meeting their laboratory services’ needs."  
 
 

blog comments powered by Disqus
  • 16th Annual $alary $urvey

    16th Annual $alary $urvey

    Tim Wright, Editor||June 3, 2015
    Welcome to Contract Pharma’s Sixteenth Annual Salary Survey! This year’s results are derived from more than 500 respondents f

  • Newsmakers: PCI

    Newsmakers: PCI

    Tim Wright, Editor||June 2, 2015
    PCI execs talk about the recent opening of the company’s new North American clinical facility, as well as other trends in the market

  • How Sterilization of Primary Packaging Influences the Results of E&L Studies

    How Sterilization of Primary Packaging Influences the Results of E&L Studies

    Thorsten Sogding, Daniel Canton, Daniel Haines, Uwe Rothhaar, SCHOTT Pharma Services ||June 2, 2015
    As the demands that are being placed on the quality and stability of medications continue to increase, the interactions that take place between the primary packaging container and filled drug product are becoming increasingly important